Cybeats signs trial license with Top-5 global medical device manufacturer
by CM staff
Cybeats SBOM Studio delivers software supply chain intelligence technology, enabling organizations to manage software bill of materials and proactively addresses cyber risks in their medical device projects.
TORONTO — Cybeats Technologies signs a trial license agreement for SBOM Studio1 with a Top-5 global medical device company, marking its 3rd engagement from the Medical Device Manufacturing (MDM) Global Top-10.
“The interest from yet another global leader from the medical device space highlights the increasing demand for SBOM management solutions like SBOM Studio, and is a testament to the value and efficacy of our product. Not only do we provide solutions for cybersecurity risk management, but also for compliance with newly mandated FDA requirements for SBOMs that ensure a smoother market entry for products,” said Yoav Raiter, CEO, Cybeats.
Cybeats SBOM Studio delivers software supply chain intelligence technology, enabling organizations to manage Software Bill of Materials (SBOM) and proactively addresses cyber risks in their medical device projects.
This recent contract, along with several recent wins from the medical device sector underscores the company’s growing expertise in the healthcare security industry vertical, and increasing demand for SBOM solutions.
During its first 12 months of commercial operations, the company has signed SBOM Studio license agreements across all of its target market verticals: Industrial Control Systems (ICS), Medical Device Manufacturers (MDM), Data Management, and Automotive sectors.
